joimax Receives 510(k) Clearance for Percusys Pedicle Screw-Rod System

IRVINE, Calif., March 4, 2015 (GLOBE NEWSWIRE) — The German company joimax®, developer of technologies and training methods for minimally invasive endoscopic spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Percusys® percutaneous pedicle screw-rod system.

The patented Percusys system is a multi-functional implant for use during spinal stabilization procedures. Its unique screw and instrument design enables a safer and more effective surgical technique with minimal steps for the surgeon. The single, small instrument set allows flexibility to perform surgery through a percutaneous, minimally invasive or open approach.

“During development, the main focus was on the ease-of-use of the system,” says Dr. Frank Hassel, specialist for spine surgery from Freiburg, Germany, who was instrumental to the Percusys development. “The idea was to reduce the complexity in instrumentation and simplify stabilization procedures to minimize the potential damage of soft tissues and improve overall patient outcomes.”

Percusys implants comprise single packaged, sterile, and pre-assembled pedicle screws with lengthening shaft and set-screw. All screws are color coded according to their diameter, cannulated, fenestrated, self-cutting and self-drilling. Each surgical step is carried out using the lengthening shaft, which is tightly connected to the tulip. The assembly allows for direct manipulation and does not require additional instrumentation. Shearing off the lengthening shaft can be done by a 360-degree rotation of the shaft breaker.

Percusyscan be usedin combination with the joimax® EndoLIF® O-Cage. “This offers an optimal solution for minimally invasive, endoscopic-assisted access to the intervertebral disc,” says Wolfgang Ries, CEO and founder of joimax. “Percusys® represents the next logical step in the development of endoscopic surgery and further strengthens the joimax position as an expert in this special market segment.”

Third international workshop on endoscopic spinal surgery using the TESSYS® method incorporating live operations

joimax® and the ATOS Private Clinic Munich present their largest international endoscopy workshop so far.

Karlsruhe, 16th September 2009
: On 14th and 15th September a joimax® workshop on the endoscopic removal of disc herniations using the TESSYS® method took place in the ATOS Private Clinic Munich for the third time. A highlight of this international workshop was the transmission of three live operations, which the 25 participating orthopaedic and neurosurgeons were able to follow in the conference room in the neighbouring Sheraton Arabellapark Hotel.
Dr. med. Michael Schubert operated on three patients from Egypt, Denmark and Germany, describing the individual steps of the procedure and answering questions from the auditorium during the operations. Several workshop participants were also able to follow the operations directly from the operating theatre. The live operations followed a day of intensive training on cadavers in the Ludwig-Maximilian University, Munich. The participants travelled from far and wide for the workshop, with surgeons from Germany, Austria, Spain, Turkey and several Asian countries taking part. Faculty member and course instructor Dr. Menno Iprenburg, who heads his own clinic in Veenhuizen, the Netherlands, claimed: “In my opinion this was the best workshop so far!”

Click on images to enlarge.

Veröffentlicht in 2009

joimax® ANNOUNCES STRATEGIC PARTNERSHIP WITH NAMSA

Taps the market access professionals to oversee reimbursement strategy

IRVINE, CA – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally-invasive spinal surgery, is pleased to announce a new strategic partnership with NAMSA, the only full continuum Contract Research Organization (CRO) in the world focused exclusively on medical devices. Recognized as a leader in reimbursement strategies, with years of experience in collaborating with public and private payors, Namsa will assist joimax®’ customers with reimbursement support services, including prior authorization and appeals support, across the United States.

“We are excited for NAMSA to serve as an exclusive partner to help patients access joimax®’ endoscopic technologies,” stated joimax® General Manager

Maximilian Ries. “We’re optimistic that with NAMSA’s assistance, and the nearly 5,000 clinical papers on endoscopic spine surgery, we will continue to expand coverage of this important, minimally-invasive technology”.

Since the creation of American Medical Association medical procedural code, CPT® 62380, Endoscopic Decompression of Neural Elements and/or Excision of Herniated Intervertebral Discs, in 2017, utilization of endoscopic spinal procedures has grown.

For details, visit www.joimax.com.

 

joimax® obtains full product registration in Thailand, and is now active in 10 Asian countries

Karlsruhe, Germany – February 27th, 2017 – joimax® further ensures its market access in Asia. The German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery is expanding its presence and recently has obtained full product registration from the Thai Food & Drug Administration (FDA). joimax® also has approvals in South Korea, China, Singapore, Indonesia, Hong Kong and Vietnam. For Malaysia, Taiwan and Japan, the certification for the product range is expected in 2017. “We are constantly pushing the registration process in Asia to extend the availability of joimax® products. Thus, joimax® is well prepared to further widen its market presence in Asia, demonstrating our commitment to the fastest growing region of the world,” states Wolfgang Ries, Founder and CEO of joimax®.

For years, joimax® has been working with the Korean Wooridul group, the world’s largest Specialized Spine Hospital Network. Starting in 2017, joimax®, together with the Wooridul Hospital in Seoul, will offer International courses for Minimally Invasive Spinal Surgery (MISS). In a series of four courses, provided in basic and advanced level, the education of international spine surgeons is ensured. The first one, chaired by joimax® faculty Dr. Sang-Ho Lee, South Korea, recently took place. The one-week training programs offer surgeons the opportunity to learn percutaneous endoscopic techniques and other minimally-invasive procedures with lectures, operation observation and hands-on-workshops. Since 2004, more than 600 spine surgeons and specialists from 41 countries have participated in these courses at Wooridul.

Participants of the National Minimal Invasive Spinal Summit Forum & 4th joimax User Meeting, held in Zhenghou City, China from Dec. 23rd until 25th, 2016
Participants of the National Minimal Invasive Spinal Summit Forum & 4th joimax User Meeting, held in Zhenghou City, China from Dec. 23rd until 25th, 2016

After the National Minimal Invasive Spinal Summit Forum, together with the 4th joimax® User Meeting in December, joimax® China, headquartered in Chengdu, will celebrate its 10th birthday in April 2017. On this occasion, numerous internationally well-known faculties will meet in Chongqing, China to share experience and expertise. Lectures and live surgeries are planned to be held in two hospitals and to be broadcasted via Internet.

joimax® presents EndoLIF® as a world premiere at the Annual Meeting of DGNC

Not yet FDA cleared

joimax® presents EndoLIF® as a world premiere at the Annual Meeting of DGNC

Karlsruhe, 24 May 2013. It has become a good tradition – but this time it will include a world premiere: As in previous years, joimax® will present a lunch symposium during the 64th Annual Meeting of the German Society of Neurosurgery DGNC to be held in Düsseldorf, Germany, on 27 May 2013. As a world premiere joimax® will introduce its novel EndoLIF® system for endoscopic stabilization of the lumbar spine. The joimax® Faculty Team had the chance to see this technology during its yearly User Meeting held at the Institute of Anatomy of the University of Mainz, Germany, in April. It will now be displayed to the broad expert audience of DGNC’s Annual Meeting.

Besides the endoscopic technology for the access to the disc compartment based on the well proven TESSYS® or iLESSYS® access method, the EndoLIF® system comprises an O-cage (oblique cage) and a screw and rod system for posterior percutaneous stabilization. The advantages of this procedure are obvious:
– Smooth, atraumatic access due to dilation of tissue
– Dura and nerves are protected by the working tubes
– Dorsal bone structures are generally not affected
– O-Cage with osteo-conductive surface providing the optimum substrate for cell growth
– Stabilization via screw and rod system for percutaneous i.e. minimally invasive positioning
Indications for this procedure are the degenerative disease of intervertebral discs, mechanical instabilities and spondylolisthesis grade I and II. CE approval is expected by summer 2013.

The joimax® lunch symposium will be chaired by Prof. Dr. Jürgen Kiwit (Berlin). Dr. Guntram Krzok (Friedrichroda) will present „TESSYS® and iLESSYS® for multiple decompression therapies“. Dr. Bernd Illerhaus (Recklinghausen) will then draw the line to the EndoLIF® technology with an outlook on future therapeutic options. „The EndoLIF® system is the next logical step in the evolution of endoscopic access technologies to the spinal canal for gentle and safe minimally invasive implantation of cages with subsequent percutaneous stabilization“, states Dr. Illerhaus with conviction.

joimax® Announces Leadership Changes,
Expands U.S. Commercial Operations

KARLSRUHE, Germany (BUSINESS WIRE) – joimax®, the German-based market leader in technologies and methodologies for full-endoscopic and minimally invasive spinal surgery, announces the transition of Founder and long-standing CEO Wolfgang Ries to Executive Chairman and the appointment of Maximilian Ries to Chief Executive Officer.

joimax Logo on glass facade. joimax is your expert in minimally invasive endoscopic spine surgery

After founding joimax® 24-years ago, Wolfgang Ries is stepping down as CEO to focus on research and development and to lead ESPINEA® Endoscopic Spine Academy, the only endoscopic training program accredited by the Royal College of Surgeons of Edinburgh.

Taking over as CEO is Maximilian Ries, who during his 16-year tenure at joimax®, held diverse leadership roles in product management, R&D, operations, and finance. He served as General Manager from 2016 to 2021 before returning to Germany in 2022 where he was most recently Executive Vice President of Global Operations and Business Development of joimax®.

joimax Logo on glass facade. joimax is your expert in minimally invasive endoscopic spine surgery

“I am honored to lead joimax® into the next phase of growth as we continue advancing our market-leading endoscopic spine technologies,” stated Maximilian Ries. “We are seeing endoscopic spine surgery emerge as the new gold standard in minimally invasive spine care — a legacy built by Wolfgang that I’m proud to continue.”

Mr. Maximilian Ries
CEO 

In the lead-up to these transitions, joimax® strengthened its U.S. commercial team with several key changes, including the promotions of Anthony Troncale to President, Levon Zanadvorov, MD to Medical Director, Joe O’Connor to Vice President of US Sales, Chris Lever to Vice President Business Operations and Finance, and Jarred Shewey to Director of Clinical Education, as well as the addition of Katherine Ray as Director of Global Marketing.

“I am handing off joimax® to a highly talented and experienced team of endoscopic spine experts under Max’s leadership,” said Wolfgang Ries. “I couldn’t be more excited about the company’s future and the continued advancement of endoscopic spine surgery.”

Mr. Wolfgang Ries
Founder and Executive Chairman 
Veröffentlicht in Allgemein

joimax® Celebrates Resounding Success at the German Spine Society (DWG) Convention 2019

Karlsruhe (GER) / Irvine, CA – December 3, 2019 – joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, celebrated resounding success at this year’s German Spine Society (DWG), held November 28 to 30 in Munich, Germany. joimax® presented its newest product innovations and hosted several informative sessions to rave reviews, exceeding expectations.

Among the products showcased was a new member of the joimax® TESSYS® family, TESSYS® Thx, a system specifically developed for the symptomatic thoracic deherniation and decompression treatment. Surgeries utilizing TESSYS® Thx can avoid complications often associated with traditional open and microsurgical approaches, such as significant muscle damage, bony resection, and morbidities.

joimax® also presented Intracs®em, the first electromagnetic system for endoscopic spine applications that can navigate instruments directly at the tip, if required. This navigation system combines side and AP images of the C-arm with the CT axial scan, providing surgeons with meaningful views of the target region. Intracs® em received its CE mark earlier this year and has been successful throughout Europe and Asia. FDA approval is pending; expected by year’s end.

Moreover, joimax® presented its Endoscopic Spine Academy ESPINEA®. This modular training program, divided into a Pre-Clinical Training with anatomical models, endoscopic tools, and simulators, and a Clinical Training, part of the joimax® CM3 program consisting of visitation, hands-on workshops, and the first surgery, offers surgeons specific support to optimize and significantly shorten the individual learning curve.

Additional highlights included, the daily Meet the Expert Sessions, a Needle Placement Challenge with attractive prizes, and a lunch symposium on “Endoscopy in the Course of Time”.

joimax® CEO and Founder Wolfgang Ries states, “Our unmatched attention to the needs of surgeons enables us to be one step ahead. The reception of our products at this convention reinforced our commitment to endoscopy and underscored the importance of showcasing innovative products such as Intracs®em.  By participating in national and international spine congresses, we are able to achieve broad market penetration for the benefit of the patient”.

joimax® hosts SpineWeek symposium, leads live surgery broadcast during CAOS-NASS

Karlsruhe, Germany and Singapore, Chengdu/Shanghai, China (May 25, 2016) – joimax®, the global developer and marketer of technologies and treatment methods for minimally invasive endoscopic spinal surgery, recently hosted an educational symposium and exhibited at SpineWeek in Singapore. SpineWeek takes place every four years and is viewed as one of the most important congresses, representing numerous international society leaders.

“The decision to participate in this congress was the right step to demonstrate our presence in the Asian region,” says Wolfgang Ries, CEO and founder of joimax®. “This year, there was a clear focus on endoscopic treatments by the participating societies, which created a strong interest in our lunch symposium. Approximately 200 attendees gathered to learn about the techniques of endoscopic minimally invasive spine surgery and the benefits of these techniques to both the surgeon and their patients,” continued Ries.

To further validate the company’s expansion and presence in China, joimax® participated in the 9th Congress of the Chinese Association of Orthopaedic Surgeons – North American Spine Society (CAOS/NASS) meeting in Chengdu, China. The company was also involved with the Master Techniques in Spine Surgery Workshop, held on May 20, 2016 in Shanghai, China. Dr. Ralf Wagner, of the Ligamenta Spine Center in Frankfurt, Germany, led the technique-focused workshop and surgery, which was broadcast live to the meeting in Chengdu, as well as online to 30,000 Chinese surgeons.

joimax® inspires Thai-German Neurosurgery Congress participants for TESSYS®

Karlsruhe, 6th of October 2011. joimax® opened doors for the Thai-German Neurosurgery congress participants, under the patronage of the German Academy for Neurosurgery (GANS) and the presidency of the Director of the Clinic for Neurosurgery at the “Städtisches Klinikum” in Karlsruhe, Prof. Dr. med. Dr. h.c. Uwe Spetzger – this year taking place in Karlsruhe, South Germany.

joimax® organised a lunch symposium in line with the congress, beginning with a company conducted tour through the facility where the participants visited amongst others the departments of the technical staff, research, development and construction – the core competencies and heart of the company. Also interesting were the explanations of the company founder and managing director Wolfgang Ries speaking about the exhibits in the so called internal “museum”, documenting the development of the 10 years company history,
showing prototypes of instruments, endoscopes and devices from the founding years.

The application of TESSYS® was presented by Prof. Dr. med. Ju?rgen Kiwit, Chief Physician of the Helios Hospital for Neurosurgery in Berlin Buch, in his demonstrative lecture with many pictures and videos. “In my opinion the minimally invasive TESSYS® method is the future of spine surgery, especially when treating herniated discs and stenosis. The advantages of this gentle method are more than obvious,” he stated.

The full potential of the endoscopic spinal surgery was impressively shown by Wolfgang Ries in his overview presentation: with special instruments it is also suitable for treating e.g. spinal canal stenosis and so makes – besides the transforaminal – the interlaminar access possible also, so that the spinal canal is now accessible from all sides, meaning 360°. The instruments of the next generation with flexible forceps, reamers and endoscopes are already very advanced in the joimax® development pipeline. An endoscopic assisted spine stabilisation system will open further wide ranges of applications.

A concluding hands-on with the latest joimax® endoscopic devices on models fully convinced the 45 Thai-German guests of the company’s innovative performance.

Thai-German_Meeting2011